Time is crucial when launching new medicines in the EU.

In our latest #podcast on public #health, MEP @DolorsMM raised concerns about long approval periods within Member States.

Listen here: 🎧 http://epp.group/s4e22

🐦🔗: https://n.respublicae.eu/EPPGroup/status/1653685839900348416